Brief: Newbury Says Sunitinib Approved In Denmark

Newbury Pharmaceuticals AB

29/03/2022 15:31

March 29 (Reuters) - Newbury Pharmaceuticals AB  NEWBRY.ST :
    * SUNITINIB NEWBURY APPROVED BY THE DANISH HEALTH
AUTHORITIES
    * MARKETING AUTHORIZATION (MA) OF SUNITINIB NEWBURY IN
DENMARK AS
FIRST COUNTRY IN A SCANDINAVIAN REGISTRATION PROCEDURE.
    * APPROVALS IN SWEDEN AND NORWAY ARE EXPECTED TO FOLLOW UPON
FINALIZED NATIONAL REVIEWS.

Source text for Eikon:  ID:nMFNHq8bG 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))